Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme

Published:2011-07-15 Issue:9 Volume:13 Page:974-982
ISSN:1523-5866
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Bai Ren-Yuan,Staedtke Verena,Aprhys Colette M.,Gallia Gary L.,Riggins Gregory J.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/13/9/974/16663579/nor077.pdf

Reference47 articles.

1. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol,2009

2. Intratumoral patterns of genomic imbalance in glioblastomas;Nobusawa;Brain Pathol,2010

3. Advances in the treatment of malignant gliomas;Khasraw;Curr Oncol Rep,2010

4. Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis;Lefranc;J Clin Oncol,2005

5. Plasma concentrations of mebendazole during treatment of echinococcosis: preliminary results;Munst;Eur J Clin Pharmacol,1980

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Severe Drug-Induced Liver Injury Due to Self-administration of the Veterinary Anthelmintic Medication, Fenbendazole;ACG Case Reports Journal;2024-05

2. Repurposing mebendazole against triple-negative breast cancer CNS metastasis;Journal of Neuro-Oncology;2024-04-02

3. Repurposing mebendazole against triple-negative breast cancer leptomeningeal disease;2024-02-05

4. A phase 1 study of mebendazole with bevacizumab and irinotecan in high‐grade gliomas;Pediatric Blood & Cancer;2024-01-17

5. Overcoming Chemotherapy Resistance in Metastatic Cancer: A Comprehensive Review;Biomedicines;2024-01-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3